PER 1.25% 8.1¢ percheron therapeutics limited

Ann: Market and Technology Update, page-90

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,743 Posts.
    lightbulb Created with Sketch. 1461
    KPKG..
    AT the time of EAP,only RMNS was considered.
    Due to others research B CELLS are in vogue.
    EUropean Clinicians are more interested in SPMS. $$$$ much bigger market .
    But to do this we have to do a small study under Prof Lamont. In Germany.
    All the data generated will apply to the Ind study in the USA.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.001(1.25%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.3¢ 8.4¢ 8.1¢ $84.93K 1.029M

Buyers (Bids)

No. Vol. Price($)
1 50582 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 40000 1
View Market Depth
Last trade - 11.10am 11/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.